AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 241 min read$AVAH

J.H. Whitney Equity Partners VII, LLC sold $169.6M of AVAH (indirect holdings)

J.H. Whitney Equity Partners VII, LLC sold 14,746,077 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $11.50 ($169.58M total) across 4 trades over 2026-08-20 to 2026-08-21.

Original reporting
SEC EDGAR · J.H. Whitney Equity Partners VII, LLC
Published Aug 24, 2026, 10:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 10:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AVAH
Bearish
high confidence
Mentioned
$AVAH
Relevance
8/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHBearishMed
01

Why it matters

The transaction reduces insider ownership and may be interpreted as reduced confidence, potentially prompting short sellers.

02

Market read

Significant insider sell provides fresh material for traders to assess AVAH's near‑term price direction.

03

What to watch

Potential upcoming earnings or strategic moves not disclosed yet.

Relevance 8/10Novelty 8/10Timing: today

Background

Form 4 filing by a 10% owner disclosing a $169.6M open‑market sale of AVAH shares.

Company-level read

Ticker impact

$AVAHBearishHigh confidence
Context

J.H. Whitney Equity Partners VII sold $169.6M of AVAH shares, reducing its stake to 12.3M shares.

Expected impact

Potential short-term downside pressure.

Evidence & confidence

The sale represents a 14.7M share reduction at $11.50 per share, a material transaction for a 10% owner.

Market effects

Sector

May weigh on healthcare services sector sentiment as a large insider exits.

Regional

Limited to US markets where AVAH trades.

Global

Minimal global impact beyond AVAH investors.

Counterpoint

What could challenge this read

The sale could be a portfolio rebalancing unrelated to company fundamentals.

Key entities

  • Company
    Aveanna Healthcare Holdings, Inc.

    Issuer of the shares sold.

  • Insider
    J.H. Whitney Equity Partners VII, LLC

    10% owner executing the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AVAH insider trading history →

Related articles

AUG 21
$AVAHMedAI 8/10

Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight

Aveanna Healthcare (AVAH) reported Q2 revenue of $670M, up 13.7% YoY, with all divisions growing. CEO Shaner announced a pediatric nursing rate increase in California starting 2027. Adjusted EBITDA rose 8% to $95.4M. The company raised full-year guidance to over $2.68B in revenue and $365M in adjusted EBITDA. However, private duty services saw higher costs per hour, and some growth was due to nonrecurring items.

insidermonkey.com3 min
AUG 21
$AVAHHighAI 8/10

Why is Aveanna Healthcare stock sliding today?

Aveanna Healthcare (AVAH) stock fell 7.6% in pre-market trading after existing shareholders, including J.H. Whitney Equity Partners and insiders, sold 15 million shares at $11.75, a discount to the prior close. The underwriter has a 30-day option to sell more shares, adding supply pressure. The company itself is not selling shares or receiving proceeds. The broader U.S. market is higher in pre-market.

investing.com2 min
AUG 20
$AVAHHighAI 9/10

Aveanna Healthcare (AVAH) Q2 2026 Earnings Call Transcript

Aveanna Healthcare (AVAH) reported Q2 2026 revenue of $670.5M, up 13.7% YoY, with adjusted EBITDA of $95.4M, up 8%. All segments grew, with Private Duty Services leading at $553.9M, up 14%. The company raised full-year revenue guidance to over $2.68B and adjusted EBITDA to over $365M. Management highlighted strategic payer alignments, acquisitions, and cost efficiencies.

fool.com3 min